Patent
   D947358
Priority
Mar 19 2019
Filed
Dec 03 2020
Issued
Mar 29 2022
Expiry
Mar 29 2037

TERM.DISCL.
Assg.orig
Entity
unknown
0
27
n/a
The ornamental design for a pill, as shown and described.

FIG. 1 is a top perspective view of a pill showing our new design;

FIG. 2 is a bottom perspective view thereof;

FIG. 3 is a front view thereof;

FIG. 4 is a rear view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a right side view thereof;

FIG. 7 is a top view thereof;

FIG. 8 is a bottom view thereof;

FIG. 9 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7;

FIG. 10 is a bottom view thereof;

FIG. 11 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7; and,

FIG. 12 is a bottom view thereof.

Asmussen, Martin, Gaunø, Mette Høg

Patent Priority Assignee Title
Patent Priority Assignee Title
6165513, Jun 11 1997 Allergan Pharmaceuticals International Limited Film-coated tablet for improved upper gastrointestinal tract safety
CN3030001,
CN304516482,
D403396, Nov 28 1996 Astra Aktiebolag Tablet
D425614, Apr 16 1999 Merck Sharp & Dohme Corp Tablet
D430285, Apr 16 1999 MERCK & CO , INC Tablet
D431076, Jul 07 1999 Merck Sharp & Dohme Corp Tablet
D434846, Jul 07 1999 Merck Sharp & Dohme Corp Tablet
D459798, Mar 26 2001 AVENTIS PHARMA S A Pill tablet
D475451, Sep 09 2002 Access Business Group International LLC Vitamin tablet
D535021, Apr 22 2005 WM WRIGLEY JR COMPANY Elliptical tablet
D564086, May 30 2005 Takeda Nycomed AS Tablet
D636865, Aug 25 2010 KVK-Tech, Inc. Pharmaceutical tablet
D671636, Apr 23 2010 DAIICHI SANKYO COMPANY, LIMITED Pharmaceutical tablet
D735315, Jun 25 2012 Amgen Inc Pharmaceutical tablet
D754841, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D787042, Apr 28 2015 Celgene Corporation Pharmaceutical tablet
D787043, Jun 23 2015 Celgene Corporation Pharmaceutical tablet
D813372, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835257, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835258, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D858741, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D906513, Mar 19 2019 Novo Nordisk A S Pill
D907760, Jan 20 2017 SOCIÉTÉ DES PRODUITS NESTLÉ S A Orally ingestible tablet
EM5896430001,
JPJ2305860200,
WO689585,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 03 2020Novo Nordisk A/S(assignment on the face of the patent)
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule